Diagnostics
-
The Care I Wish Our Parents Had
As a daughter who has been through the wringer a few times, I write today to all health care leaders trying to build a better future.
-
Healthcare Hires of Note
Read about executive hires across healthcare and life sciences.
-
Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It’s beginning to attract the attention of major healthcare organizations.
-
A Preview of Healthcare Startups at HLTH 2022
Startups will be plentiful at the upcoming HLTH conference at the Venetian Expo in Las Vegas November 13-16. Here’s a glimpse of some of the healthcare pain points they’re addressing.
-
FDA narrows EUAs for Covid-19 tests, steering companies to traditional review pathways
The FDA said it will review fewer Covid-19 diagnostics for emergency use authorization. The policy update follows an Office of Inspector General report that found the urgency to increase testing availability led to problems, including the authorization of many low-quality tests.
-
BioMEMS founder shares his vision for changing how diagnostics are developed, deployed and administered
Andrew Dahl, founder and chairman of BioMEMS Diagnostics, shared how his business seeks to transform the diagnostics sector, in response to emailed questions.
-
StartUPDATES: New developments from healthcare startups
Check out new developments from BioMEMS Diagnostics, Neuroflow, Druglike, Health Note, and Rhinostics.
-
Devices & Diagnostics, BioPharma
LabCorp plans to break out its $6B drug development biz as a standalone company
Laboratory testing and clinical trial services giant LabCorp plans to spin off its drug development business as an independent, publicly traded company. It’s the latest in a string of corporate moves for the life sciences sector as companies look to streamline operations in order to focus on particular areas of growth.
-
StartUPDATES: New developments from healthcare startups
Check out new developments from Seven Bridges, Healthmine, Bright Health, and My One Medical Source.
-
Pandemic Response Lab CEO discusses its approach to laboratory automation
In addition to developing rapid testing for Covid-19, PRL has developed a non-diagnostic sequencing workflow for rapid variant detection and tracking.
-
Navigating Healthcare’s Data Revolution: Priorities, Opportunities, and Challenges for Health Systems
Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here’s what we found.
-
BioPharma, Devices & Diagnostics, SYN
Sherlock Biosciences secures $80M to bring molecular diagnostics to the home
Diagnostics developer Sherlock Biosciences has advanced its molecular diagnostic capabilities, which can now produce faster results on low-cost devices. The startup will use its Series B round of funding to expand the reach of its technology, potentially placing it directly in the hands of consumers around the world.
-
Devices & Diagnostics, Artificial Intelligence
Freenome gets $290M from Roche as it preps blood-based cancer test’s next steps
A month after Freenome closed $300 million in financing, Roche has invested another $290 million in the diagnostics developer. The cash infusion comes as Freenome continues a pivotal test in colorectal cancer while it also readies for clinical trials in other types of cancer.
-
Time is running out to apply to pitch your healthcare startup at MedCity INVEST
The deadline to apply to the MedCity INVEST Pitch Perfect contest in Chicago, scheduled for March 28-30 at the Ritz Carlton, is January 31.
-
As genetic testing expands, evidence and awareness needed to spur adoption
Genetic tests are becoming available for a wider range of applications. During a CB Insights panel discussion, Phil Febbo of Illumina and Alicia Zhou of Color explained what they think needs to happen to make these tests accessible and affordable for more people.
-
A preview of MedCity INVEST 2022: A return to in-person conferences
INVEST, scheduled for March 28-30, 2022 in Chicago, marks a return to in-person events for MedCity News. The conference, held in partnership with Mid-America Healthcare Investors Network, will spotlight healthcare innovation, investment trends, and share insights from healthcare executives.
-
Devices & Diagnostics, Diagnostics
GE plans to spin out healthcare business in 2023
General Electric plans to spin out its healthcare business into a publicly traded entity in 2023. It’s part of a broader restructuring as the company looks to turn around its business.